Steven E. Lipshultz, M.D.
Professor of Pediatrics
Description of Research
Dr. Lipshultz’s research interest focuses on how to prevent cardiomyopathy and heart failure in children and young adults. He developed the National Heart, Lung, and Blood Institute (NHLBI) Pediatric Cardiomyopathy Registry (PCMR) to better understand the genetic and metabolic cardiomyopathies, developed the NHLBI P2C2 HIV study to better understand infectious and inflammatory cardiomyopathies, and created the NCI DFCI childhood leukemia and NCI COG childhood cancer survivor cohorts to better understand toxic cardiomyopathies from anthracycline chemotherapy and mediastinal irradiation. Further understanding of clinical phenotypes, human syndrome delineation, epidemiology, and natural history of these pediatric diseases has resulted from these cohorts.Highlights
- Developed the National Heart, Lung, and Blood Institute (NHLBI) Pediatric Cardiomyopathy Registry (PCMR) to better understand the genetic and metabolic cardiomyopathies
- Developed the NHLBI P2C2 HIV study to better understand infectious and inflammatory cardiomyopathies
- Created the NCI DFCI childhood leukemia and NCI COG childhood cancer survivor cohorts to better understand toxic cardiomyopathies from anthracycline chemotherapy and mediastinal irradiation
Selected Cancer-Related Publications
- Harmon WG, Sleeper LA, Cuniberti L, Messere J, Colan SD, Orav EJ, Towbin JA, Wilkinson JD, Lipshultz SE. Treating children with idiopathic dilated cardiomyopathy (from the Pediatric Cardiomyopathy Registry). Am J Cardiol 104:281-6, 2009. Read more »
Programs
Collaborating in the Multidisciplinary Research Program(s):